ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 182 filers reported holding ACORDA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 4.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,474,000 | -31.5% | 75,000 | 0.0% | 0.43% | -26.3% |
| Q2 2018 | $2,152,000 | +82.1% | 75,000 | +50.0% | 0.58% | +77.1% |
| Q1 2018 | $1,182,000 | -38.2% | 50,000 | -33.3% | 0.33% | +12.0% |
| Q2 2016 | $1,913,000 | -71.1% | 75,000 | -70.0% | 0.29% | -66.6% |
| Q1 2016 | $6,613,000 | +54.6% | 250,000 | +150.0% | 0.88% | +44.2% |
| Q4 2015 | $4,278,000 | +193.4% | 100,000 | +81.8% | 0.61% | +228.1% |
| Q3 2015 | $1,458,000 | -67.8% | 55,000 | -59.6% | 0.18% | -64.7% |
| Q2 2015 | $4,533,000 | -35.1% | 136,000 | -35.2% | 0.52% | -28.5% |
| Q1 2015 | $6,989,000 | – | 210,000 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |